✦ LIBER ✦

Lobular carcinoma in situ with microinvasion

✍ Scribed by Nemoto, Takuma; Castillo, Nieva; Tsukada, Yoshi; Koul, Ashok; Eckhert, Kenneth H.; Bauer, Ronald L.

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 255 KB
Volume: 67
Category: Article
ISSN: 0022-4790
DOI: 10.1002/(sici)1096-9098(199801)67:1<41::aid-jso9>3.0.co;2-m

No coin nor oath required. For personal study only.

✦ Synopsis

Six patients with lobular carcinoma in situ with microinvasion were described in this report. Lobular carcinoma in situ is not known to progress to microinvasive disease. Although this feature is rare, the current understanding that lobular carcinoma in situ is a marker needs to be revised.

📜 SIMILAR VOLUMES

Mammary ductal carcinoma in Situ with mi

Mammary ductal carcinoma in Situ with microinvasion

✍ Susan A. Silver; Fattaneh A. Tavassoli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

## Background: The natural history of patients with intraductal carcinoma (dcis) and microinvasion is poorly defined, and the clinical management of these patients, with particular reference to management of the axilla, has been controversial. previous studies of this lesion have used varied and/or

Lymph node metastasis from ductal carcin

Lymph node metastasis from ductal carcinoma in situ with microinvasion

✍ Jeffry Zavotsky; Nora Hansen; Meghan B. Brennan; Roderick R. Turner; Armando E. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

BACKGROUND. Widespread use of mammography has increased the detection of ductal carcinoma in situ with microinvasion (DCISM) in pathology specimens. Currently there is disagreement regarding the incidence of axillary metastasis from DCISM. The controversy centers on whether complete lymphadenectomy

Lobular carcinoma in situ of the breast

✍ R. A. A. Macaulay; Dr M. J. Mitchinson 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 1 views

Clinicopathologic implications of E-cadh

Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast

✍ Neal S. Goldstein; Larry L. Kestin; Frank A. Vicini 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

Lobular carcinoma in Situ of the breast:

Lobular carcinoma in Situ of the breast: An approach to rational treatment

✍ Johan A. Andersen 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

A review of 3299 benign breast lesions was carried out. Lobular carcinoma in sifu (LCIs) was discovered in 52 cases; and of these, 44 had been treated by biopsy alone. During the follow-up period averaging 15.9 years, 1 1 patients developed invasive breast cancer (IBC): 9 ipsilateral lesions, and 4

Despite limited data, coexistent lobular

Despite limited data, coexistent lobular carcinoma in situ should not be a contraindication to breast conservation for women with invasive breast carcinoma

✍ Harry D. Bear; W. Hans Carter Jr.; Margaret M. Grimes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

L ong after prospective randomized trials demonstrated equivalent survival with breast-conserving treatment (BCT) and mastectomy for breast carcinoma patients, BCT is used less than would be expected, particularly in certain regions of the United States. 1,2 Many different reasons have been given fo